NEW YORK, Jan 22 (Reuters) - The Federal Trade Commission is investigating Turing Pharmaceuticals for possible antitrust violations following the company's decision to raise the price of a life-saving medicine, a lawyer for former Chief Executive Martin Shkreli wrote on Friday.
